Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Post by inspecthrgadgeton Jul 23, 2020 3:37pm
122 Views
Post# 31309968

30s a little high Beech.

30s a little high Beech.

 People that took $12M without free warrant were saying 4 and then 3 cents. Other friend now buying said 5 cents and then under review and then slipped out of Alter-Cyte. Speaking of witch, has PWC accounting identified the unknown director with the 2%?

Why no farewell speech for Ed?  He was the fellow that said 2 to 1 ratios in favour of proposed treatments were common in confirmatory 28 day mortality trial affairs. 


The US has this buy the jewels and everyone has to play along. Did I mention the CTSO German Sepsis trial debacle or their current FDA suspended trial effort?  Nice to be punked by bullboard peeps!  $10 US and no gard data huh?  Another Kiacta Dredger?
 

Bullboard Posts